OpenAI acquires Orchestra Bio for drug-development AI agents
Orchestra will fold into Rosalind; terms were not disclosed, and OpenAI already works with Novo Nordisk and Moderna.
46
- Mentions · 7d0
- Mentions · 30d3
- All mentions3
- First seenOct 20, 2026
- Last mentioned9d ago
Timeline
3 articles · newest firstOpenAI acquires Orchestra Bio for its Rosalind life-sciences work
Terms were undisclosed; the four-year-old startup had reportedly raised about $20 million by 2025.
44
OpenAI acquires Orchestra Bio to extend Rosalind life-sciences tools
Orchestra’s drug-program agents will join GPT-Rosalind and Rosalind Workbench to coordinate studies and timelines.
46
Appears with
- Rosalind Workbenchproduct · 3
- Novo Nordiskorganization · 3
- OpenAIvendor · 2
- Orchestra Bioorganization · 2
- GPT-Rosalindai model · 2
- Rosalindproduct · 2
- OpenAIorganization · 1
- Orchestra Bioproduct · 1
- Rosalindai model · 1
Entities are extracted by the model from each article. First seen , last mentioned . Watching keeps it in this browser only (no account); the watchlist page and dashboard alerts use it.